Pat Mackin

Insider profile

Currently holds positions in Artivion Inc and Wright Medical Group NV

Performance

Overall performance
3.6

Performance over holding periods
3.6
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
22 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer, Director Artivion Inc April 10, 2015 -
Non-Executive Independent Director Wright Medical Group NV June 1, 2018 -
President, Chief Executive Officer, Director Artivion Inc Oct. 21, 2014 - April 10, 2015
President, Chief Executive Officer Artivion Inc Sept. 2, 2014 - Oct. 21, 2014

Pat Mackin's trades of Artivion Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-04 2026-03-03 S Sale
95,298 -21.4%
464.73
US$1,172,943
95,298 -21.4% 464.73 US$1,172,943
2026-03-03 2026-03-03 PrS Proposed sale
18,949
86.03
US$2,403,144
18,949 86.03 US$2,403,144
2026-03-03 2026-03-02 S Sale
68,245 -25.9%
52.46
US$4,123,232
68,245 -25.9% 52.46 US$4,123,232
2026-03-02 2026-03-02 PrS Proposed sale
14,911
38.02
US$566,989
14,911 38.02 US$566,989
2026-02-25 2026-02-24 S Sale
13,936 -1.8%
35.69
US$497,418
13,936 -1.8% 35.69 US$497,418
2026-02-24 2026-02-24 PrS Proposed sale
13,936
35.69
US$497,416
13,936 35.69 US$497,416
2026-02-25 2026-02-23 S Sale
20,962 -2.6%
37.59
US$787,920
20,962 -2.6% 37.59 US$787,920
2026-02-23 2026-02-23 PrS Proposed sale
20,962
37.59
US$787,909
20,962 37.59 US$787,909
2025-12-04 2025-12-03 PlS Planned sale
30,921 -3.7%
45.46
US$1,405,700
30,921 -3.7% 45.46 US$1,405,700
2025-12-03 2025-12-03 PrS Proposed sale
30,921
45.46
US$1,405,695
30,921 45.46 US$1,405,695
2025-12-03 2025-12-02 PlS Planned sale
30,921 -3.7%
45.56
US$1,408,730
30,921 -3.7% 45.56 US$1,408,730
2025-12-02 2025-12-02 PrS Proposed sale
30,921
46.27
US$1,430,715
30,921 46.27 US$1,430,715
2025-11-14 2025-11-13 S Sale
34,210 -4.1%
45.86
US$1,568,802
34,210 -4.1% 45.86 US$1,568,802
2025-11-13 2025-11-13 PrS Proposed sale
34,210
45.86
US$1,568,812
34,210 45.86 US$1,568,812
2025-11-12 2025-11-10 PrS Proposed sale
17,580
44.62
US$784,400
17,580 44.62 US$784,400
2025-11-12 2025-11-10 S Sale
17,580 -2.1%
44.62
US$784,402
17,580 -2.1% 44.62 US$784,402
2025-08-19 2025-08-15 S Sale
12,500 -1.4%
42.32
US$528,988
12,500 -1.4% 42.32 US$528,988
2025-08-15 2025-08-15 PrS Proposed sale
12,500
42.32
US$528,991
12,500 42.32 US$528,991
2025-03-10 2025-03-06 PlS Planned sale
70,700 -7.6%
24.76
US$1,750,843
70,700 -7.6% 24.76 US$1,750,843
2025-03-10 2025-03-06 S Sale
17,739 -2.0%
24.80
US$440,005
17,739 -2.0% 24.80 US$440,005
2025-03-06 2025-03-06 PrS Proposed sale
70,700
24.76
US$1,750,843
70,700 24.76 US$1,750,843
2025-02-26 2025-02-24 S Sale
4,896 -0.7%
27.31
US$133,690
4,896 -0.7% 27.31 US$133,690
2025-02-26 2025-02-24 S Sale
6,812 -1.0%
27.31
US$186,008
6,812 -1.0% 27.31 US$186,008
2025-02-26 2025-02-24 S Sale
13,784 -2.0%
27.31
US$376,386
13,784 -2.0% 27.31 US$376,386
2025-02-26 2025-02-24 S Sale
16,664 -2.4%
27.31
US$455,027
16,664 -2.4% 27.31 US$455,027
2024-03-07 2024-03-05 S Sale
13,996 -1.9%
18.72
US$262,037
13,996 -1.9% 18.72 US$262,037
2024-02-29 2024-02-27 S Sale
4,837 -0.7%
19.83
US$95,939
4,837 -0.7% 19.83 US$95,939
2024-02-28 2024-02-26 S Sale
13,168 -1.9%
20.27
US$266,930
13,168 -1.9% 20.27 US$266,930
2024-02-28 2024-02-26 S Sale
18,144 -2.7%
20.27
US$367,799
18,144 -2.7% 20.27 US$367,799
2024-02-22 2024-02-20 S Sale
2,756 -0.5%
18.87
US$51,992
2,756 -0.5% 18.87 US$51,992
2024-02-22 2024-02-20 S Sale
10,088 -1.8%
18.87
US$190,310
10,088 -1.8% 18.87 US$190,310
2024-02-22 2024-02-20 PlS Planned sale
59,225 -9.7%
18.85
US$1,116,516
59,225 -9.7% 18.85 US$1,116,516
2024-02-20 2024-02-20 PrS Proposed sale
59,225
18.85
US$1,116,516
59,225 18.85 US$1,116,516
2023-03-03 2023-03-02 S Sale
9,990 -1.8%
13.41
US$133,984
9,990 -1.8% 13.41 US$133,984
2023-03-01 2023-02-27 S Sale
9,985 -1.8%
12.94
US$129,186
9,985 -1.8% 12.94 US$129,186
2023-03-01 2023-02-27 S Sale
12,645 -2.4%
12.94
US$163,601
12,645 -2.4% 12.94 US$163,601
2023-02-16 2023-02-14 PlS Planned sale
56,500 -10.1%
13.22
US$747,207
56,500 -10.1% 13.22 US$747,207
2022-02-11 2022-02-10 PlS Planned sale
10,639 -3.4%
17.86
US$189,998
10,639 -3.4% 17.86 US$189,998
2022-02-11 2022-02-09 PlS Planned sale
10,638 -3.4%
18.14
US$192,989
10,638 -3.4% 18.14 US$192,989
2022-02-10 2022-02-08 PlS Planned sale
10,638 -3.4%
17.75
US$188,771
10,638 -3.4% 17.75 US$188,771
2022-02-08 2022-02-07 PlS Planned sale
10,638 -3.4%
17.30
US$184,052
10,638 -3.4% 17.30 US$184,052
2021-05-04 2021-04-30 PlS Planned sale
29,469 -8.8%
28.00
US$825,132
29,469 -8.8% 28.00 US$825,132
2021-05-04 2021-04-30 PlS Planned sale
16,265 -5.1%
28.00
US$455,420
16,265 -5.1% 28.00 US$455,420
2019-05-07 2019-05-03 S Sale
50,000 -18.5%
31.31
US$1,565,690
50,000 -18.5% 31.31 US$1,565,690